Trump names surgeon general, FDA, CDC leaders
Fox News medical contributor Janette Nesheiwat as surgeon general led a flurry of senior staff hires announced by President-elect Donald Trump.
Related Articles
Partial regression of conventional renal cell carcinoma displays markers of wound repair
Aims During detailed analysis of H&E-stained histological slides of 710 unbiased conventional renal cell carcinomas (cRCCs), 141 tumours displayed partial regressive changes showing strong similarity…
Allograft Renal Cell Carcinoma From the Donor: Rare, but Possible
Important takeaways from a rare complication
Epic, Oracle and the push for international EHR dominance
Oracle Health and Epic are looking at the electronic health records market in countries where the digitization of healthcare lags behind the U.S.
Harnessing AI in Financial Services: Synechron’s Data Strategy, Overcoming Challenges, and Future Innovations
Podcast Episode · What’s Up with Tech? · 10/21/2024 · 23m
Cybertruck Values Have Cratered And Are Still Dropping
Tesla’s signature wildly swinging MSRPs aren’t helping
Rare myxoid pleomorphic liposarcoma: a case report and literature review
We report a case of a middle-aged woman with a rapidly growing abdominal mass that was diagnosed as myxoid pleomorphic liposarcoma, a recently recognised, rare…
Asteroid worth $10,000,000,000,000,000,000 NASA is capturing would give everyone on Earth $1,246,105,919 each
A SpaceX rocket was launched to explore the 16 Psyche asteroid last month
How the EHR can ruin your documentation—and increase legal liability
Learn how to improve EHR documentation – prevent errors – to increase patient safety and decrease physicians’ liability risk.
Revolutionizing Digital Workplaces: Lenovo’s AI-Driven Services, Strategic Security Partnerships, and Future Enterprise Innovations
Podcast Episode · What’s Up with Tech? · 10/25/2024 · 23m
Trump’s win could alter plans for these startups
Executives at transgender and abortion care startups are expressing concern with the incoming administration’s rhetoric around their patient populations.